Free Account Opening + AMC Free Demat
Loading...

Cosmo First Buyback vs Jenburkt Pharmaceuticals Buyback

Comparision between Cosmo First Buyback and Jenburkt Pharmaceuticals Buyback.

Buyback Details

Cosmo First Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Jenburkt Pharmaceuticals Buyback is a Open Market Through Stock Exchange proposed to list at BSE.

  Cosmo First Limited Jenburkt Pharmaceuticals Ltd
Logo Cosmo First Buyback Logo Jenburkt Pharmaceuticals Buyback Logo
Type of Buyback Tender Offer Open Market Through Stock Exchange
Listing At BSE, NSE BSE
Face Value ₹10 per share ₹10 per share
Buyback Price ₹1070 per share ₹702 per share
Issue Size 10,09,345 shares
Issue Size (Amount) ₹108.00 Crores ₹11.60 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders8 Equity Shares out of every 121 Fully paid-up Equity Shares held on the Record Date.151,402.00
General Category for all other Eligible Shareholders29 Equity Shares out of every 844 Fully paid-up Equity Shares held on the Record Date.857,943.00
Registrar Link Intime India Private Ltd Bigshare Services Pvt Ltd
Lead Managers Anand Rathi Securities Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)
Necessity of the buyback

The buyback is being undertaken for the following reason:

  • The Buyback will improve financial ratios like earnings per share, return on capital employed and return on equity, calculated on the basis of financial statements, by reduction in the equity basis of the Company, thereby leading to long term increase in shareholders' value.
  • The Buyback will help in achieving an optimal capital structure.
  • The Buyback will help the Company to distribute surplus cash to the Eligible Shareholders broadly in proportion to their shareholding, thereby, enhancing their overall return.

The buyback is being undertaken for the following reason:

  • The company is expected to achieve the objective of returning surplus funds to the shareholders, improving return on equity through distribution of surplus funds, improving earnings per share by reduction in equity base and increasing shareholders' value in the long term by improving key return ratios.
  • The Buyback will lead to reduction in outstanding Equity Shares of the Company, improvement in 'earnings per share' and enhanced return on equity.

Buyback Timetable

Cosmo First Buyback and Jenburkt Pharmaceuticals Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Cosmo First Buyback Buyback record date is Dec 14, 2022. Jenburkt Pharmaceuticals Buyback Buyback record date is .

  Cosmo First Limited Jenburkt Pharmaceuticals Ltd
Record Date Dec 14, 2022
Offer Open Date Jan 27, 2023 Dec 14, 2022
Offer Closure Date Feb 09, 2023 Mar 24, 2023
Last date for receipt of tender forms Feb 09, 2023
Finalisation of buyback Feb 17, 2023
Last Date for settlment of bids Feb 20, 2023
Last Date for extinguishment of shares Feb 27, 2023

Financial Details and Other Relevent Information

Comparison of Cosmo First Buyback and Jenburkt Pharmaceuticals Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Cosmo First Limited Jenburkt Pharmaceuticals Ltd
Financial
Cosmo First Limited Financial Information (Consolidated)
Period EndedTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-202222.99113.44726.63707.19789.45
31-Mar-212322.92136841.19823.02760.29
31-Mar-223086.71396.611175.431157.26810.05
30-Sep-221638.91166.531332.61305.34839.16
Amount in ₹ Crore
Jenburkt Pharmaceuticals Ltd Financial Information (Restated)
Period EndedTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-20123.1114.8782.345.18
31-Mar-21113.616.598.855.07
31-Mar-22128.9322.3116.466.76
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2022 814.20 657.95 738.71
Oct-2022 899.30 728.05 812.91
Sep-2022 929.90 837.05 880.26

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2022 645.15 572.00 590.12
Oct-2022 577.25 548.65 563.91
Sep-2022 605.95 535.70 581.48
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2022 815.00 658.10 738.94
Oct-2022 895.55 728.80 812.42
Sep-2022 925.00 837.00 880.57

Comments

Add a public comment...